Rosenberg Matthew Hamilton increased its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 831 shares of the medical research company’s stock after acquiring an additional 37 shares during the period. Rosenberg Matthew […]